PET evidence for a role of the basal ganglia in patients with ring chromosome 20 epilepsy

Neurology

Volumn 63, Issue 1, 2004, Pages 73-77

  Biraben, Arnaud ^a   Semah, F ^b   Ribeiro, M J ^b   Douaud, G ^b   Remy, P ^b,c   Depaulis, A ^d  

^a PONTCHAILLOU UNIVERSITY HOSPITAL   (France)

^b DIF   (France)

^c UNIVERSITÉ PARIS EST CRÉTEIL   (France)

^d UNIV GRENOBLE ALPES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

6 FLUORODOPA F 18;

ADOLESCENT; ADULT; ARTICLE; BASAL GANGLION; CLINICAL ARTICLE; DOPAMINERGIC TRANSMISSION; EPILEPSY; FEMALE; HUMAN; MALE; MOSAICISM; NEUROTRANSMISSION; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RING CHROMOSOME; RING CHROMOSOME 20 EPILEPSY; STRIATE CORTEX;

EID: 3242703069     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/01.WNL.0000132840.40838.13     Document Type: Article

References (45)

1. Deransart C, Vercueil L, Marescaux C, Depaulis A. The role of basal ganglia in the control of generalized absence seizures. Epilepsy Res 1998;32:213-223.
2. Depaulis A, Vergnes M, Marescaux C. Endogenous control of epilepsy: the nigral inhibitory system. Prog Neurobiol 1994;42:33-52.
3. Deransart C, Marescaux C, Depaulis A. Involvement of nigral glutamatergic inputs in the control of seizures in a genetic model of absence epilepsy in the rat. Neuroscience 1996;71:721-728.
4. Benabid AL, Minotti L, Koudsie A, et al. Antiepileptic effect of high-frequency stimulation of the subthalamic nucleus (Corpus Luysi) in a case of medically intractable epilepsy caused by focal dysplasia: a 30-month follow-up: technical case report. Neurosurgery 2002;50:1385-1392.
5. Deransart C, Riban V, Le B, et al. Dopamine in the striatum modulates seizures in a genetic model of absence epilepsy in the rat. Neuroscience 2000;100:335-344.
6. Cavalheiro EA, Turski L. Intrastriatal N-methyl-D-aspartate prevents amygdala kindled seizures in rats. Brain Res 1986;377:173-176.
7. Turski L, Cavalheiro EA, Calderazzo-Filho LS, et al. The basal ganglia, the deep prepyriform cortex, and seizure spread: bicuculline is anticonvulsant in the rat striatum. Proc Natl Acad Sci USA 1989;86:1694-1697.
8. Garant DS, Gale K. Substantia nigra-mediated anticonvulsant actions: role of nigral output pathways. Exp Neurol 1987;97:143-159.
9. Henry TR, Mazziotta JC, Engel J Jr, et al, Quantifying interictal metabolic activity in human temporal lobe epilepsy. J Cereb Blood Flow Metab 1990;10:748-757.
10. Dupont S, Semah F, Samson Y, Baulac M. The underlying pathophysiology of ictal dystonia in temporal lobe epilepsy: an FDG-PET study. Neurology 1998;51:1289-1292.
11. Newton MR, Berkovic SF, Austin MC, et al. Dystonia, clinical lateralization, and regional blood flow changes in temporal lobe seizures. Neurology 1992;42:371-377.
12. Starr MS. The role of dopamine in epilepsy. Synapse 1996;22:159-194.
13. Canevini MP, Sgro V, Zuffardi O, et al. Chromosome 20 ring: a chromosomal disorder associated with a particular electroclinical pattern. Epilepsia 1998;39:942-951.
14. Inoue Y, Fujiwara T, Matsuda K, et al. Ring chromosome 20 and nonconvulsive status epilepticus. A new epileptic syndrome. Brain 1997;120:939-953.
15. Petit J, Roubertie A, Inoue Y, Genton P. Non-convulsive status in the ring chromosome 20 syndrome: a video illustration of 3 cases. Epileptic Disord 1999;1:237-241.
16. ISCN (1995): An international system for human cytogenetic nomenclature, Mitelman F, ed. Basel: S. Karger, 1995.
17. Ashburner J, Friston KJ. Voxel-based-morphometry: the methods. NeuroImage 2000;11:805-821.
18. Ribeiro MJ, Vidailhet M, Loc'h C, et al. Dopaminergic function and dopamine transporter binding assessed with positron emission tomography in Parkinson disease. Arch Neurol 2002;59:580-586.
19. 18F]fluorodopa uptake in five grafted parkinsonian patients. Ann Neurol 1995;38:580-588.
20. DeCarli C, Hatta J, Fazilat S, et al. Extratemporal atrophy in patients with complex partial seizures of left temporal origin. Ann Neurol 1998;43:41-45.
21. Dreifuss S, Vingerhoets FJ, Lazeyras F, et al. Volumetric measurements of subcortical nuclei in patients with temporal lobe epilepsy. Neurology 2001;57:1636-1641.
22. 18F-DOPA uptake: absence of an aging effect. J Cereb Blood Flow Metab 1993;13:881-888.
23. Kaasinen V, Rinne JO. Functional imaging studies of dopamine system and cognition in normal aging and Parkinson's disease. Neurosci Biobehav Rev 2002;26:785-793.
24. Ichikawa J, Meltzer HY. Valproate and carbamazepine increase prefrontal dopamine release by 5-HT1A receptor activation. Eur J Pharmacol 1999;380:R1-R3.
25. Baf MH, Subhash MN, Lakshmana KM, Rao BS. Sodium valproate induced alterations in monoamine levels in different regions of the rat brain. Neurochem Int 1994;24:67-72.
26. Vriend JP, Alexiuk NA. Effects of valproate on amino acid and monoamine concentrations in striatum of audiogenic seizure-prone Balb/c mice. Mol Chem Neuropathol 1996;27:307-324.
27. Loscher W. Valproate: a reappraisal of its pharmacodynamic properties and mechanisms of action. Prog Neurobiol 1999;58:31-59.
28. Armon C, Shin C, Miller P, et al. Reversible parkinsonism and cognitive impairment with chronic valproate use. Neurology 1996;47:626-635.
29. Onofrj M, Thomas A, Paci C. Reversible parkinsonism induced by prolonged treatment with valproate. J Neurol 1998;245:794-796.
30. Yatham LN, Liddle PF, Shiah IS, et al. PET study of [(18)F]6-fluoro-L- dopa uptake in neuroleptic- and mood-stabilizer-naive first-episode nonpsychotic mania: effects of treatment with divalproex sodium. Am J Psychiatry 2002;159:768-774.
31. Jones-Humble SA, Morgan PF, Cooper BR. The novel anticonvulsant lamotrigine prevents dopamine depletion in C57 black mice in the MPTP animal model of Parkinson's disease. Life Sci 1994;54:245-252.
32. Southam E, Kirkby D, Higgins GA, Hagan RM. Lamotrigine inhibits monoamine uptake in vitro and modulates 5-hydroxytryptamine uptake in rats. Eur J Pharmacol 1998;358:19-24.
33. Schiffer WK, Gerasimov MR, Marsteller DA, et al. Topiramate selectively attenuates nicotine-induced increases in monoamine release. Synapse 2001;42:196-198.
34. Millan MJ, Gobert A, Girardon S, Dekeyne A. Citalopram elicits a discriminative stimulus in rats at a dose selectively increasing extracellular levels of serotonin vs. dopamine and noradrenaline. Eur J Pharmacol 1999;364:147-150.
35. D'Aquila PS, Peana AT, Tanda O, Serra G. Carbamazepine prevents imipramine-induced behavioural sensitization to the dopamine D(2)-like receptor agonist quinpirole. Eur J Pharmacol 2001;416:107-111.
36. Joca SR, Skalisz LL, Beijamini V, et al. The antidepressive-like effect of oxcarbazepine: possible role of dopaminergic neurotransmission. Eur Neuropsychopharmacol 2000;10:223-228.
37. Fall PA, Ekman R, Granerus AK, et al. ECT in Parkinson's disease. Changes in motor symptoms, monoamine metabolites and neuropeptides. J Neural Transm Park Dis Dement Sect 1995;10:129-140.
38. Strecker RE, Moneta ME. Electrical stimulation of the kindled hippocampus briefly increases extracellular dopamine in the nucleus accumbens. Neurosci Lett 1994;176:173-177.
39. Dazzi L, Serra M, Porceddu ML, et al. Enhancement of basal and pentylenetetrazol (PTZ)-stimulated dopamine release in the brain of freely moving rats by PTZ-induced kindling. Synapse 1997;26:351-358.
40. Mirovsky Y, Wagner GC, Sekowski A, et al. Simultaneous changes in striatal dopamine, serotonin, and metabolites after withdrawal seizures in rats from dependence on alcohol. Alcohol 1995;12:251-256.
41. Alam AM, Starr MS. Regional changes in brain dopamine utilization during status epilepticus in the rat induced by systemic pilocarpine and intrahippocampal carbachol. Neuropharmacology 1996;35:159-167.
42. Morrish PK, Sawle GV, Brooks DJ. Regional changes in [18F]dopa metabolism in the striatum in Parkinson's disease. Brain 1996;119:2097-2103.
43. Phillips HA, Scheffer IE, Berkovic SF, et al. Localization of a gene for autosomal dominant nocturnal frontal lobe epilepsy to chromosome 20q 13.2. Nat Genet 1995;10:117-118.
44. Torta R, Monaco F. Atypical antipsychotics and serotoninergic antidepressants in patients with epilepsy: pharmacodynamic considerations. Epilepsia 2002;43(suppl 2):8-13.
45. Deransart C, Le BT, Marescaux C, Depaulis A. Role of the subthalamonigral input in the control of amygdala-kindled seizures in the rat. Brain Res 1998;807:78-83.